Shengtao Zhou

20PUBLICATIONS
108CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsCancer cell biologyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 24, 2026
Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies.

|Apr 07, 2026
Correcting Mitochondrial Complex I Defect in Tumor-Associated Natural Killer Cells Potentiates Immunotherapy for Glioblastoma.

Nianxin Zhou, Fan Fei, Lin Tang

|Mar 03, 2026
Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial.

Jie Lin, Qiaoling Wu, Bin Liu

|Jan 09, 2026
Spatiotemporal Immune Determinants of Response to Immune Rechallenge in Advanced Cervical Cancer.

Chunyan Lan, Peidong Zhang, Jing Zhao

|Nov 26, 2025
Molecular and Immune Correlates of Response to First-Line De-escalated Chemotherapy plus Penpulimab and Anlotinib in Advanced Cervical Cancer.

Qin Xu, Zhengrong Deng, Jing Liu

|Jan 25, 2025
Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies.

Yi Du, Yang Yang, Bohao Zheng

Pageof 4

Frequent Collaborators

6 joint publications

Linjie Zhao

4 joint publications

Peidong Zhang

4 joint publications

Jeremy N Rich

3 joint publications

Wei Wang